ÁñÁ«ÊÓƵ

Grant winners ¨C 7 July 2016

<ÁñÁ«ÊÓƵ class="standfirst">A round-up of recent recipients of research council cash
July 7, 2016
Grant winners tab on folder
<ÁñÁ«ÊÓƵ>Arts and Humanities Research Council

Research grants

Editing Aphra Behn in the digital age (E-ABIDA)


Language acts and worldmaking


<ÁñÁ«ÊÓƵ>Leverhulme Trust

Research Project Grants
Sciences

Data-driven discovery of correlations between genes and ageing-related changes


New frontiers in lipoprotein analysis: small molecules, big questions?


Unravelling photoprotection pathways in plant sunscreens


<ÁñÁ«ÊÓƵ>National Institute for Health Research

Efficacy and Mechanism Evaluation Programme

GEM3: A multi-centre double-blind placebo-controlled randomised trial of a combination of methotrexate and gefitinib versus methotrexate alone as a treatment for ectopic pregnancy

ÁñÁ«ÊÓƵ

ADVERTISEMENT

Screening programme for pre?eclampsia (SPREE)


Health Technology Assessment Programme

Investigating the effectiveness and cost-effectiveness of using FITNET to treat paediatric CFS/ME in the UK


<ÁñÁ«ÊÓƵ>MRC/BBSRC/ EPSRC/ESRC

Joint awards by the Medical Research Council, the Biotechnology and Biological Sciences Research Council, the Engineering and Physical Sciences Research Council and the Economic and Social Research Council

ÁñÁ«ÊÓƵ

ADVERTISEMENT

Cross-council awards to tackle antibiotic resistance

Accelerating development of infection diagnostics for patient management and reduction of antibiotic misuse


Optimising innate host defence to combat AMR


<ÁñÁ«ÊÓƵ>In detail

Award winner: Andrew Bailey
Institution: University of Bristol
Value: ?2.2 million

Exploring nature¡¯s silent pharmacy

Penicillin, the first antibiotic, was derived from fungi in 1941, and the organisms have continued to be an important source of antimicrobial drugs ever since. This project will use contemporary technology to revisit old compounds in the hope of discovering new benefits that might have been missed first time around. Cutting-edge computing methods will allow researchers to sequence the entire genome of a fungus, which was not possible before with traditional drug discovery methods. This could point researchers to a wide range of undiscovered natural compounds that, if bioactive, could lead to much-needed new types of antibiotics.

ÁñÁ«ÊÓƵ

ADVERTISEMENT

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Register
Please Login or Register to read this article.
<ÁñÁ«ÊÓƵ class="pane-title"> Related articles
<ÁñÁ«ÊÓƵ class="pane-title"> Sponsored
<ÁñÁ«ÊÓƵ class="pane-title"> Featured jobs
ADVERTISEMENT